Orthofix Medical Inc. (OFIX)
Orthofix Medical Statistics
Share Statistics
Orthofix Medical has 39.02M shares outstanding. The number of shares has increased by 2.16% in one year.
| Shares Outstanding | 39.02M |
| Shares Change (YoY) | 2.16% |
| Shares Change (QoQ) | 0.1% |
| Owned by Institutions (%) | 85.86% |
| Shares Floating | 37.5M |
| Failed to Deliver (FTD) Shares | 86 |
| FTD / Avg. Volume | 0.04% |
Short Selling Information
The latest short interest is 790.28K, so 2.07% of the outstanding shares have been sold short.
| Short Interest | 790.28K |
| Short % of Shares Out | 2.07% |
| Short % of Float | 2.15% |
| Short Ratio (days to cover) | 3.33 |
Valuation Ratios
The PE ratio is -5.37 and the forward PE ratio is -619.67. Orthofix Medical's PEG ratio is 0.25.
| PE Ratio | -5.37 |
| Forward PE | -619.67 |
| PS Ratio | 0.83 |
| Forward PS | 0.7 |
| PB Ratio | 1.32 |
| P/FCF Ratio | -73.28 |
| PEG Ratio | 0.25 |
Enterprise Valuation
Orthofix Medical Inc. has an Enterprise Value (EV) of 591.55M.
| EV / Earnings | -4.78 |
| EV / Sales | 0.74 |
| EV / EBITDA | -32.43 |
| EV / EBIT | -6.99 |
| EV / FCF | -65.11 |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.36.
| Current Ratio | 2.57 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.36 |
| Total Debt / Capitalization | 26.31 |
| Cash Flow / Debt | 0.14 |
| Interest Coverage | -2.86 |
Financial Efficiency
Return on equity (ROE) is -0.25% and return on capital (ROIC) is -12.61%.
| Return on Equity (ROE) | -0.25% |
| Return on Assets (ROA) | -0.14% |
| Return on Capital (ROIC) | -12.61% |
| Revenue Per Employee | $494,734.53 |
| Profits Per Employee | $-76,655.32 |
| Employee Count | 1,616 |
| Asset Turnover | 0.89 |
| Inventory Turnover | 1.34 |
Taxes
| Income Tax | 2.12M |
| Effective Tax Rate | -0.02 |
Stock Price Statistics
The stock price has increased by 10.4% in the last 52 weeks. The beta is 1.06, so Orthofix Medical's price volatility has been higher than the market average.
| Beta | 1.06 |
| 52-Week Price Change | 10.4% |
| 50-Day Moving Average | 17.62 |
| 200-Day Moving Average | 16.71 |
| Relative Strength Index (RSI) | 35.4 |
| Average Volume (20 Days) | 207.16K |
Income Statement
In the last 12 months, Orthofix Medical had revenue of 799.49M and earned -123.88M in profits. Earnings per share was -3.25.
| Revenue | 799.49M |
| Gross Profit | 545.88M |
| Operating Income | -84.62M |
| Net Income | -123.88M |
| EBITDA | -18.24M |
| EBIT | -84.62M |
| Earnings Per Share (EPS) | -3.25 |
Balance Sheet
The company has 83.24M in cash and 179.63M in debt, giving a net cash position of -96.39M.
| Cash & Cash Equivalents | 83.24M |
| Total Debt | 179.63M |
| Net Cash | -96.39M |
| Retained Earnings | -276.14M |
| Total Assets | 893.29M |
| Working Capital | 264.66M |
Cash Flow
In the last 12 months, operating cash flow was 25.79M and capital expenditures -34.88M, giving a free cash flow of -9.09M.
| Operating Cash Flow | 25.79M |
| Capital Expenditures | -34.88M |
| Free Cash Flow | -9.09M |
| FCF Per Share | -0.24 |
Margins
Gross margin is 68.28%, with operating and profit margins of -10.58% and -15.49%.
| Gross Margin | 68.28% |
| Operating Margin | -10.58% |
| Pretax Margin | -15.49% |
| Profit Margin | -15.49% |
| EBITDA Margin | -2.28% |
| EBIT Margin | -10.58% |
| FCF Margin | -1.14% |
Dividends & Yields
OFIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -20.27% |
| FCF Yield | -1.45% |
Analyst Forecast
The average price target for OFIX is $24, which is 49.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $24 |
| Price Target Difference | 49.7% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Scores
| Altman Z-Score | 1.45 |
| Piotroski F-Score | 5 |